Alexandria Venture Investments was among the participants in a series A for the cellular cancer therapeutics developer based on work at Institut Curie and Memorial Sloan Kettering.
Mnemo Therapeutics, a France-based cellular therapeutics developer advancing research from Institut Curie and Memorial Sloan Kettering Cancer Center, closed a €75m ($91m) series A round on Wednesday led by Casdin Capital.
Alexandria Venture Investments, a vehicle for life sciences real estate investment trust Alexandria Real Estate Equities, backed the round, as did Redmile, Emerson Collective and Sofinnova Partners, the last of which had taken part in a seed round of undisclosed size in 2019.
Mnemo is developing CAR…
